Priority Date: 08.03.13 (US 201361774946P)

EGFR MUTATION BLOOD TESTING

  • Application ID: EP14708273
  • Status: EXAMINATION IN PROGRESS

Applicants

Technology company logo small
Technology Company
Technology company logo small
Technology Company

Attorneys

no operation time available
3 offices
Technology Company
no operation time available
3 offices
Technology Company

Specialization

This EP application has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Roche Diagnostics GmbH is specialized in C12. Roche Diagnostics GmbH, Roche Diagnostics GmbH is specialised in C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 08.03.2013 - Priority Date (US 201361774946P)
  • 12.09.2014 - Publication A1 (WO2014135669)
  • 13.01.2016 - Publication A1 (EP2964781)

IPC Classification